Journal
CELL METABOLISM
Volume 28, Issue 3, Pages 432-+Publisher
CELL PRESS
DOI: 10.1016/j.cmet.2018.05.027
Keywords
-
Categories
Funding
- NIH [HL111483, AI105845, HL066436]
Ask authors/readers for more resources
Pathogen burden accelerates atherosclerosis, but the mechanisms remain unresolved. Activation of the NLRP3 inflammasome is linked to atherogenesis. Herewe investigatedwhether Chlamydia pneumoniae (C. pn) infection engages NLRP3 in promoting atherosclerosis. C. pn potentiated hyperlipidemia-induced inflammasome activity in cultured macrophages and in foam cells in atherosclerotic lesions of Ldlr(-/-) mice. C. pn-induced acceleration of atherosclerosis was significantly dependent on NLRP3 and caspase-1. We discovered that C. pn-induced extracellular IL-1 beta triggers a negative feedback loop to inhibit GPR109a and ABCA1 expression and cholesterol efflux, leading to accumulation of intracellular cholesterol and foam cell formation. Gpr109a and Abca1 were both upregulated in plaque lesions in Nlrp3(-/-) mice in both hyperlipidemic and C. pn infection models. Mature IL-1 beta and cholesterol may compete for access to the ABCA1 transporter to be exported from macrophages. C. pn exploits this metabolic-immune crosstalk, which can be modulated by NLRP3 inhibitors to alleviate atherosclerosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available